spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 3


Fig. 3. Effects of opioid receptor stimulation on DEPV-induced cardiomyocyte apoptosis. (A) Representative electrophoretic analysis of nucleosomal DNA fragmentation from six experiments, showing the effect of morphine or DADLE on DEPV-induced cardiomyocyte apoptosis in the presence or absence of the nonselective-, {kappa}-, or {delta}-opioid receptor antagonist. (B) Representative Hoechst 33258 staining from six experiments, showing morphine-induced protection against DEPV-induced cardiomyocyte apoptosis. a, control; b, DEPV; c, DEPV + MOR; d, DEPV + MOR + NAL. Bar, 20 µm. (C) The effect of morphine or DADLE on DEPV-induced cardiomyocyte apoptosis in presence or absence of the nonselective-, {kappa}-, or {delta}-opioid receptor antagonist. Bar chart shows the percentage of apoptotic cells, as assessed by TUNEL staining, in each group (n=6 in each group). Values are the mean ± s.d. *P<0.05 among the indicated groups. DEPV, serum and glucose deprivation; DADLE, [D-Ala2, D-Leu5]-enkephalin acetate salt; NAT, natrindole; MOR, morphine; NAL, naloxone; GNTI, guanidinyl-naltrindole.





Right arrow Return to article